Prostatitis and chronic prostatitis/chronic pelvic pain syndrome

Abstract

The prevalence of prostatitis is extremely high, with up to 16% of men diagnosed with prostatitis at some point throughout their lifetime. However, the etiology appears to be multifactorial and standard treatment regimens have been altered significantly in recent years. The purpose of this review is to examine the changing scientific views on the causes and treatment of prostatitis, chronic prostaitis and chronic pelvic pain syndrome. We review the infectious and noninfectious etiology of the disease, examining the role of antimicrobial treatment in eradicating infection as well as ameliorating symptoms. Current NIH classifications, which stratify prostatitis into four categories, are discussed, as is the NIH Chronic Prostatitis Symptom Index, the primary tool used to assess symptomatology. Diagnostic examinations are studying the need for the four-glass test and its practical replacement by the two-glass test. Multimodal treatment therapy is then discussed, including recent data on biofeedback and evaluation of the role of pelvic floor dysfunction in prostatitis.

Traditional Chinese medicine on treating chronic prostatitis/chronic pelvic pain syndrome

“…would also become visible. [1–2] Some patients may also suffer from dizziness, memory loss, sexual dysfunction, and even depression. [3] Epidemiological investigations have shown that 2.2% to 13.8% of adult men are suffering from it, and approximately 30% to 50% of men would suffer from it in particular periods of their lives.…”

Clinical efficacy of roxithromycin in men with chronic prostatitis/chronic pelvic pain syndrome in comparison with ciprofloxacin and aceclofenac: A prospective, randomized, multicenter pilot trial

“…Antibiotics have a successful treatment rate of approximately 40% of prostatitis cases, and antibiotics improve prostatitis symptoms independent of the category of chronic prostatitis [5]. Fluoroquinolone antibiotics have been traditionally preferred for treatment.…”

Consolidation therapy is necessary following successful biofeedback treatment for pubertal chronic prostatitis patients: A 3-year follow-up study

“…3 Pelvic-floor biofeedback training has been applied to the treatment of CP, whereby specific instruments are used to teach patients how to contract and relax pelvic muscles selectively, while keeping other muscles relaxed. 4,5 There are few reports regarding the treatment of pubertal patients with CP. The authors of the present study published data on 25 male adolescents with CP who underwent biofeedback training and obtained satisfactory short-term results.…”